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Beyond DNA origami:
the unfolding prospects of
nucleic acid nanotechnology
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Nucleic acid nanotechnology exploits the programmable molecular recognition
properties of natural and synthetic nucleic acids to assemble structures with
nanometer-scale precision. In 2006, DNA origami transformed the field by
providing a versatile platform for self-assembly of arbitrary shapes from one
long DNA strand held in place by hundreds of short, site-specific (spatially
addressable) DNA ‘staples’. This revolutionary approach has led to the creation
of a multitude of two-dimensional and three-dimensional scaffolds that form the
basis for functional nanodevices. Not limited to nucleic acids, these nanodevices
can incorporate other structural and functional materials, such as proteins and
nanoparticles, making them broadly useful for current and future applications in
emerging fields such as nanomedicine, nanoelectronics, and alternative energy.
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INTRODUCTION
Nucleic acid nanotechnology has been utilizedby nature for billions of years.1,2 DNA in
particular is chemically inert enough to reliably
store genetic information over even millions of
years.3 Packaged in genomes, DNA is expressed
in a regulated fashion with assistance from its
more rapidly hydrolyzed structural analog, RNA,
as well as protein factors.2,4,5 Complementarily, the
enhanced functionality of RNA is exploited in many
biological nanomachines, such as the ribosome6
and the spliceosome,7,8 for the ‘data processing’
that accompanies gene expression. Nature also uses
the specificity of base pairing by nucleic acids
for database maintenance and readout via the
modulation of gene expression by noncoding RNAs
(ncRNAs).4,9
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Inspired by nature, researchers over the past four
decades have explored nucleic acids as convenient
building blocks to assemble novel nanodevices.1,10
Because they are composed of only four different
chemical building blocks and follow relatively
simple, yet highly specific and thus predictable
organizational base pairing rules at the molecular
scale, nucleic acids are the preferred biological
material for the design of structures with nanometer
precision when compared with other candidates
such as proteins. Short [typically <50 nucleotides
(nt) for RNA and <100 nt for DNA] specific
sequences of the building blocks can be chemically
synthesized at low cost, whereas longer DNA strands
of predefined sequence are provided by nature
in the form of genomic DNA. A combination
of these two sources led to the advent of the
DNA origami method in 2006,11 which dramatically
accelerated progress in nucleic acid nanotechnology
by further increasing the simplicity, precision,
and fidelity of the design principles available for
generating spatially addressable nanoscale structures
(Box 1). Numerous DNA origami-based nucleic
acid nanodevices and nanomaterials have since been
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constructed12–16 with great potential for a multitude
of useful applications and with abundant prospects
for innovation.
BOX 1: DNA ORIGAMI
The invention of scaffolded DNA origami
was a milestone in the advancement of
nucleic acid nanotechnology. Developed by Paul
Rothemund, DNA origami is the assisted folding
of one long ssDNA ‘scaffold’ strand from a
bacterial phage genome consisting of 7249
nucleotides into a predetermined shape by
∼200 typically 32-nt-long ssDNA ‘staple’ strands
containing sequences that are complementary
to specific regions of the scaffold strand.
Two or more nonadjacent segments of the
scaffold strand are brought together and
held in place by hybridization to different
portions of the same staple oligonucleotide in
aggregate (Figure 3(a)), enabling the creation
of arbitrary shapes based solely on the staple
sequences (Figure 3(b) and (c)). The staples may
be extended at their 5′ ends to make them
addressable for patterning with a resolution
of 6 nm on the assembled origami, imposed by
the interstaple distance on the assembled DNA
duplexes of the origami11 (Figure 3(d)).
While building on previous approaches
to self-assembly of DNA nanostructures, the
DNA origami technique has multiple advan-
tages: (1) It accomplishes highly specific topolo-
gies with a spatially addressable resolution
comparable to that accomplished by surface
manipulation using atomic force microscopy
(AFM) or scanning tunneling nicroscopy (STM).
(2) The well-formed, redundant self-assembly is
relatively insensitive to varying stoichiometric
ratios of the staples, eliminating the need for
intermittent purification steps and resulting in
higher yields. (3) Multiple nanostructures may
be obtained simultaneously and possibly fur-
ther assembled into larger structures with high
fidelity. (4) Creating arbitrary shapes that are
largely unrestricted by symmetry considerations
is relatively straightforward.11
The DNA origami method has so far
provided a scaffold for many applications
including forming the track for molecular
nanorobots,47 constructing ordered molecular
assembly lines,48,49 and assembling components
for nanoelectronic circuits.50,51 The scope and
limitations of these applications are enumerated
throughout.
THE BUILDING MATERIALS:
NATURAL NUCLEIC ACIDS
Nucleic acids are linear biopolymers found in all
organisms, as well as many viruses, as they are
the means by which genetic information is stored,
transferred, and regulated. Their monomeric building
blocks (nucleotides) each consist of three moieties
(Figure 1(a)–(c)): a nucleobase, a five-carbon sugar,
and a phosphate group. The phosphate group
enables the formation of a phosphodiester bond
between the sugars of adjacent nucleotides, creating
a polymer known as a single-stranded nucleic acid.
Complementary nucleobases can form hydrogen
bonds which, along with stacking interactions
between adjacent base pairs, result in two fully
complementary polymers hybridizing to form a
relatively rigid antiparallel double-stranded helix17
(Figure 1(d)). This famous Watson–Crick duplex
has an average dimension (rise) of 0.34 nm
(for canonical B-form DNA) between the base
pairs along the helical axis and a diameter of
2 nm, ideally suited to engineer nanotechnological
structures.
Nature has optimized two different types of
nucleic acids through evolution: DNA and RNA,
which both consist of four nucleotide building blocks
that tend to pair in a predictable Watson–Crick
fashion (Figure 1(d)). The guanine–cytosine (G:C)
base pair forms three hydrogen bonds, stronger than
the two hydrogen bonds of the adenosine–thymine
(A:T) pair, used in DNA, or the adenosine–uracil
(A:U) pair, used in RNA. The primary chemical
difference between DNA and RNA is their
sugars (Figure 1(a)); ribose, the sugar found in
RNA, contains an extra 2′-hydroxyl group not
present in deoxyribose, the sugar found in DNA,
causing the backbone of RNA to hydrolyze ∼
108- to 1010 times more quickly than that of
DNA18 (Figure 1(a)). The A-form RNA duplex,
however, is more thermally stable than the B-form
DNA duplex, even though RNA is predominantly
found single-stranded in nature and forms mostly
intramolecular helices.19 These structural differences
between DNA and RNA are functionally exploited by
nature.
DNA
While the most notable purpose of DNA is storing
and maintaining the genetic blueprint of an organ-
ism, DNA performs other structural roles in the
cell as well. For instance, the guanine-rich single-
stranded telomeres at the ends of chromosomes can
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FIGURE 1 | Chemical structures of nucleic acids. Nucleotide backbone structures for (a) DNA (left), RNA (right), (b) PNA, and (c) LNA. The right
side of panel (a) also indicates the backbone hydrolysis reaction of RNA, where ‘AH+’ and ‘B’ are an acid and base catalyst, respectively. (d) Structure
of a double-stranded nucleic acid incorporating the four principal natural nucleobases A, T/U, G, and C, as well as the artificial P:Z base pair.
form topologically more complex quadruplex struc-
tures built around square stacks of four guanine bases
stabilized by a chelated metal ion (preferably K+)
at their center. G-quadruplexes thus play important
roles in the maintenance of linear eukaryotic genomes
and possibly in gene expression regulation.20 Simi-
larly, so-called Holliday four-way junctions of two
entwined DNA duplexes play critical roles in DNA
recombination.21 Forming and resolving such higher-
order structures often requires the aid of external
factors such as proteins. For example, complexes of
histone proteins facilitate the compact folding of ∼1
m of DNA into chromosomes that fit inside a ∼ 6-
µm-wide nucleus while still remaining accessible for
gene expression.22,23 In cases where decreased stability
would be most beneficial, a lower melting temperature
may be achieved by increasing the ratio of A:T to G:C
base pairs, as is desirable for promoter regions in DNA
(regions that need to melt for an RNA polymerase to
initiate gene expression24).
RNA
In the central dogma of molecular biology, the por-
trayed function of RNA is as the messenger between
DNA and protein, carrying the blueprints for protein
formation from the DNA genome so that they may
be translated by the ribosome into proteins.25 How-
ever, over the past few decades, the pervasiveness and
importance of RNA that does not code for proteins
have been increasingly appreciated. Typically, these
ncRNAs directly or indirectly regulate or mediate
gene expression at the transcriptional or transla-
tional level, making them candidates for therapeutic
applications.4,9,26 Some ncRNAs simply make use of
molecular recognition through base pairing, such as
in the RNA interference pathway.26 Others exploit
conformational dynamics of RNA.27 For example,
riboswitches regulate gene expression via the confor-
mational change induced by the RNA binding a small-
molecule metabolite or second messenger.28 Still other
ncRNAs promote catalysis, such as in peptide bond
formation within the ribosome6,29 or cleavage of RNA
via hydrolysis of the sugar-phosphate backbone30; the
activity of each of these RNA enzymes (ribozymes)
is dictated by its tertiary structure. While these activ-
ities are currently difficult to engineer from scratch
due to the large number (hundreds to thousands) of
nucleotides required and our limited understanding
of the underlying mechanisms, these functional, struc-
turally complex ncRNAs have already been optimized
by nature as active components in cellular machines.
THE BUILDING MATERIALS:
MODIFIED NUCLEIC ACIDS
Nucleic acids undergo chemical base modifications
in vivo, impacting their cellular functions. For
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example, cytosine methylation prevents DNA from
being digested by methylation-sensitive restriction
enzymes in bacteria,31 and in many eukaryotic
organisms, it is involved in the epigenetic regulation
of gene expression.32 In an analogous fashion,
researchers have synthetically modified nucleotides
to increase thermodynamic and chemical stability
as well as specificity of interactions. For instance,
locked nucleic acids (LNA) are engineered with an
extra methylene bridge between the 2′-oxygen and
4′-carbon of ribose, ‘locking’ the ribose in the 3′-
endo conformation (Figure 1(c)), which leads to a
particularly stable A-form helix with enhanced base
stacking and backbone preorganization as well as
significantly increased melting temperature, specificity
of base pairing, and nuclease resistance.33,34 Other
chemical modifications of the nucleic acid backbone
commonly used for enhancing intracellular stability
while still often supporting biological function of
an ncRNA include 2′-O-methyl, 2′-amino, 2′-fluoro,
and phosphorothioate substitutions35 (Figure 1(a)).
As a more drastic modification, peptide nucleic
acids (PNA) have an uncharged backbone of N-
(2-aminoethyl)-glycine units joined by a peptide
bond, resulting in higher thermal stability between
PNA/DNA strands than corresponding DNA/DNA
strands36 (Figure 1(b)). The uncharged nature and
nuclease resistance of PNA make it an appealing
option for nanodevices37 and 2D nucleic acid
arrays.38
Not only can the nucleic acid backbone be
modified but also the nucleobases themselves.
A particularly far-reaching example is the artificial
expansion of the genetic alphabet by an additional,
differently hydrogen bonded base pair such as Z:P
(or 6-amino-5-nitro-3-(1′-β-D-2′-deoxyribo furano
syl)-2(1H)-pyridone paired with 2-amino-8-(1′-β-D-
2′-deoxyribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4
(8H)-one, respectively; Figure 1(d)), which increases
hybridization specificity while still allowing for spe-
cific recognition by DNA-binding enzymes.39
Whereas the improved thermal and chemical
stability often found in modified nucleic acids will
prove useful for nanostructures, incorporation is
nontrivial; nanostructure design is heavily dependent
on helical twist, which is typically different between
modified and unmodified nucleic acids.10 This hurdle
will, however, be overcome with improved and
expanded design rules. In addition, these materials
can already be used to site-specifically decorate DNA
scaffolds since they form canonical Watson–Crick
base pairs.
THE PRESENT STATE OF NUCLEIC
ACID NANOTECHNOLOGY
By employing the knowledge acquired from observing
nature and building upon it, nanostructures not found
in nature have been engineered that encompass a
broad range of design objectives. The following
are examples of successful nanostructures grouped
according to their purpose.
Scaffolding
Nucleic acid scaffolds are nanostructures that may
be functionalized for ordering and arraying materials
with nanometer precision. Scaffolds were originally
formed by combining different short double-stranded
DNA (dsDNA) domains joined in a programmable
fashion using single-stranded DNA (ssDNA) over-
hangs known as ‘sticky ends’.40 While the stiffness
of dsDNA makes it a suitable raw material for the
edges of stable two- and three-dimensional structures,
the vertices of such structures remain flexible, result-
ing in a range of angles between domains.40 Inspired
by naturally occurring Holliday junctions,21,41 more
rigid structures were accomplished using reciprocal
exchange to generate double42 and triple crossover
motifs43 (Figure 2). As an alternative to combining
multiple domains, which results in variable yields
of assembled structures without defined boundaries,
increased yield and stability are accomplished using
Rothemund’s DNA origami method (Box 1 and
Figure 3), leading to more sophisticated 2D and 3D
(a)
(b)
FIGURE 2 | DNA crossover motifs. Examples for (a) double and
(b) triple crossover motifs . The red strands show how the two and three
helices, respectively, are linked.
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(a)
(b)
(c)
(d)
FIGURE 3 | The DNA origami method. (a) The single-stranded DNA
‘scaffold’ strand (purple) is folded and held in place by specifically
hybridizing ‘staple’ strands (red and green). (b) Resultant rectangular
origami tile once all the staples have bound to the scaffold. (c) Triple
crossover motifs demonstrated by the staples interacting with the
scaffold. (d) 5′ ends of the staples are extended to create overhangs,
which then can be decorated with partially complementary
oligonucleotides (purple).
structures ranging from smiley faces11 to octahedra44
and nanoflasks45 that can be concatenated into larger
structures.11,46
Dynamic Devices Constructed on Nucleic
Acid Scaffolds
To add functionality to the scaffolds, DNA, RNA,
and protein have further been used to construct
dynamic devices serving as proofs of principle for
directed transport and nanoscale assembly factories.
Molecular walkers analogous to the motor proteins
myosin, kinesin, and dynein have been constructed
completely or primarily from DNA and have attained
increasing levels of autonomy as well as responsive-
ness to external instruction52,53 (Figure 4(a)). Some
such transporters are capable of dozens to potentially
thousands of directed steps and have been shown to
walk processively along tracks on DNA origami.47,52
Directed walkers have also aided in the combinatorial
assembly of different sized gold nanoparticles48 or the
multistep synthesis of a small organic compound,49 in
the former case aided by two-state DNA conforma-
tional switches (Figure 4(b)). Coupling such devices
with DNA computing,54 either on the scaffold or
in solution, may further improve the complexity and
range of responses to environmental stimuli or instruc-
tions.
In addition to the above devices made pri-
marily of nucleic acids, several groups have sought
to augment the functional repertoire of DNA and
RNA nanotechnology through conjugation to other
nanomaterials, using self-assembled DNA structures
as a scaffold on which to position non-nucleic-
acid components that impart some new catalytic,
electronic, photonic, or structural functionality. For
instance, placing the metabolically linked enzymes
luciferase and NAD(P)H-dependent FMN oxidore-
ductase (NFOR) in close proximity on a DNA tem-
plate led to more efficient recycling of their common
FMN/FMNH2 cofactor and an overall enhancement
of the catalyzed reaction rates, mimicking the strategy
of substrate channeling often employed by nature.58
DNA origami has been used to create junctions of car-
bon nanotubes with precisely defined geometry,50,51
in one case behaving like a nanoscale field-effect
transistor50 (Figure 4(c)). Furthermore, DNA tem-
plates have directed the assembly of chromophores
such as organic dyes and quantum dots for the directed
transfer of photonic energy through fluorescence reso-
nance energy transfer (FRET),55,59,60 with the prospect
of developing photonic circuits or artificial photosyn-
thetic antenna complexes (Figure 4(d)). Conjugating
DNA to small organic molecules or polymers has
yielded materials with interesting thermal proper-
ties, such as solid DNA that only melts at 95◦C.61
Hybrids of nucleic acids and synthetic polymers show
promise for drug delivery and diagnostics.62 Finally,
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FIGURE 4 | Current state-of-the-art of
nucleic-acid-based nanotechnology. (a) Molecular
nanorobot walking along a track generated by
decorating a rectangular origami with leg footholds
(substrates); below, origami tile (boxed) imaged
using AFM over time, indicating spider movement.
(Reprinted with permission from Ref 47. Copyright
2010 Nature Publishing Group) (b) Multistep
synthesis of an organic compound mediated by a
deoxyribozyme. (Reprinted with permission from
Ref 49. Copyright 2010 Nature Publishing Group)
(c) Junctions of carbon nanotubes and origami to
create a field-effect transistor. (Reprinted with
permission from Ref 50. Copyright 2010 Nature
Publishing Group) (d) Transfer of photonic energy
along a DNA template using FRET. (Reprinted with
permission from Ref 55. Copyright 2010 American
Chemical Society) (e) Triangular DNA origami
arranged using electron-beam lithography.
(Reprinted with permission from Ref 56. Copyright
2010 Nature Publishing Group) (f) DNA nanotubes
arranged using soft lithography. (Reprinted with
permission from Ref 57. Copyright 2007 Wiley)
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proteins may also be employed as integral struc-
tural components of nucleic acid nanoassemblies. For
instance, assemblies shaped like equilateral triangles
were formed from an RNA-binding protein and an
RNA strand bearing the appropriate binding motif.63
Combining Bottom-up with Top-down
Techniques
So far, we have described nanoassemblies built
using bottom-up techniques (i.e., the creation of
more complicated structures self-assembled from
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fundamental units). While these techniques yield
highly resolved structures that may be generated in
parallel, they are so far still limited in their dimensions,
making them unappealing for applications where truly
large-scale patterning is required. By contrast, most
current technology outside of nanotechnology uses
top-down techniques, namely, the ordered assembly
of components by externally controlled means. For
example, many lithographic top-down fabrication
methods are able to serially generate structures
with features typically on the order of microns
(e.g., for silicon-based computer chips) but at great
capital expense for equipment. By combining top-
down and bottom-up techniques, a more affordable
large-scale (>1 mm) patterned array with nanometer
addressability may be accomplished.64 Electron
beam65 and soft57 lithography techniques have been
used to pattern DNA nanostructures across a surface
with spacings of ∼300 nm and ∼5 µm, respectively
(Figure 4(e) and (f)).
ENVISIONING FUTURE APPLICATIONS
We envision that the basic materials and concepts
of nucleic acid nanotechnology outlined so far will
further be recombined to create devices capable of
accomplishing an ever wider variety of tasks, particu-
larly in the following fields (Figure 5).
Molecular Computing
Modern-day computers are capable of performing
incredibly complex calculations with impressive
speeds. At the computer’s core, these complex
calculations are made possible by large series of binary
digital circuits incorporating logic gates. Analogously,
nucleic acids can behave as logic gates. For instance,
the output ‘true’ for an AND logic gate can be
represented by a deoxyribozyme cleaving its substrate
if and only if both DNA strand A and DNA
strand B are present in solution66 (Figure 6). Using
variations on this basic concept, nucleic acids have
completed tasks with a range of complexities from
competitively playing tic-tac-toe67 to mimicking field
programmable gate arrays68 and neural networks.69
Nucleic-acid-based logic gates inherently function
based on thermodynamic mass action and chemical
kinetics laws (i.e., probabilistic behavior), rather
than the deterministic, digital on–off switches of
silicon-based computers. Computing by nucleic acid
nanotechnology therefore will more closely mimic the
‘fuzzy logic’ and feedback loops of ant colonies and
the human brain, with corresponding advantages in
adaptability and complex pattern analysis.70 As such,
it will likely find ample application in both probing
and interfacing with biology.
Plasmonics
When metallic nanoparticles interact with visible elec-
tromagnetic waves, their conduction-band electrons
are excited, resulting in a phenomenon known as
plasmon resonance.71,72 These nanoparticles placed
in close proximity (<2.5 times the diameter of
the nanoparticle) undergo strong near-field coupling
with field enhancements.73 However, the optimal
field enhancement is dependent on the geometry of
the nanoparticle array, requiring precise nanoparti-
cle placement and spacing.71,73 To this end, gold
nanoparticles have been assembled on DNA origami
triangles.56,74 While DNA origami tiles are advan-
tageous in their rigidity and addressability, they are
limited in length (∼100 nm) unless concatenated, in
turn limiting the propagation of the plasmon reso-
nance signal. In the future, the longer scaffolds, such
as the nanopeapod75 or DNA origami nanotube76
with lengths on the order of tens of microns, will
be paired with top-down microfabrication techniques
to construct larger nanoparticle arrays with preci-
sion and spacing on the order of tens of nanometers.
Applications will likely include communication sys-
tems that merge electronics and photonics (optics) at
the nanoscale.71
Biosensors
Biosensors are small, self-contained devices that
detect and report the concentration of an analyte
through physical interaction.77 Several types of
biosensors have been constructed from nucleic
acids (e.g., aptazyme-based78 or pH-sensitive79), the
most common being optical biosensors in which
the hybridization between the analyte and its
complementary capture strand immobilized on the
surface results in a change in fluorescent signal.77
To be effective, such a technique requires a highly
specific interaction between the capture strand and
the analyte and low yield of false-positive results.
Increased specificity has already been accomplished
by incorporating synthetic nucleic acids,80,81 although
there is still room for improvement, for example,
with the further development of modified nucleotides.
One of the causes of false-positive signals is cross-
talk between neighboring capture strands.82 The
spacing between neighboring biosensor units may
be determined with nanometer precision by using
a DNA origami scaffold, enabling a high density of
capture strands on the surface while limiting their
interactions. Such scaffold techniques have recently
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FIGURE 5 | Hierarchy of areas impacted by DNA origami
technology. The foundational DNA scaffolds (green) are used to create
devices (blue) for a broad variety of applications (orange) that can be
combined to enhance numerous emerging interdisciplinary fields
(purple). Note that the nucleic acid nanotechnology field will not be
limited by our current vision.
been utilized to detect analyte concentrations as low
as 200 pM, and it was found that the hybridization
sensitivity was dependent on probe position.83
In addition, precisely arranged biosensor arrays
with enhanced and possibly synergistic detection
properties for complex samples are now within
grasp.
Organic Synthesis
Unlike conventional organic synthesis, which is
performed one step at a time with pure reagents, the
cell is capable of catalyzing thousands of reactions
simultaneously in the same vessel with extremely
high specificity and efficiency. DNA scaffolds and
devices may provide a way to emulate this approach
by virtue of their programmable nanoscale structure
and ability to spatially organize catalysts and
reagents. DNA origami, in combination with single-
stranded overhangs, conformational DNA switches,
and/or DNA walkers, have been used for multistep
organic synthesis,49 programmable assembly of
dendrimeric oligomers,84 and dynamically controlled
combinatorial assembly of gold nanoparticles.48
Since DNA origami are currently expensive to
produce in large quantities, practical applications
may be restricted in the short term to small-scale
syntheses, those that must be performed under
mild conditions or those that are not feasible
using conventional synthetic chemistry—for example,
when high-resolution control of reactant positioning
(different than that afforded by surface or metal
ion coordination chemistry)84 is required. Such
syntheses are abundant in nature and exemplified
by the assembly lines of multidomain polyketide
synthases that generate a large number of bioactive
compounds.85 Another exciting prospect enabled by
coupling DNA origami to other dynamic devices is
the ability to make chemical reactions or noncovalent
molecular assembly responsive to environmental
cues.48 For instance, signals from a host organism
might provide cues for a smart molecular ‘assembly
line’ to synthesize one of many possible products
depending on intracellular conditions at a particular
time.
Synthetic Biology
Synthetic biology is concerned with engineering natu-
ral or artificial biological systems to better understand
biological phenomena or for practical uses such as
food, drug, fuel production, or novel therapeutic
approaches.86,87 While most synthetic biology has
made use of pre-existing pathways by altering them for
a particular purpose or inserting them into a different
organism (top-down approach),86 it may become pos-
sible to construct entirely novel artificial organisms88
and pathways to allow for more predictable and
tractable performance (bottom-up approach).86 DNA
origami and similar scaffolds could contribute to such
systems by allowing for spatial and chemical coupling
of related enzymes in a manner analogous to natural
multienzyme complexes, a concept that has recently
been demonstrated on simpler DNA templates89 in
vitro and in highly concatenated RNA scaffolds in
bacteria. (The latter demonstrates one clear advantage
of RNA for many synthetic biology applications: it is
readily transcribed from a plasmid inserted into the
host organism.) Three-dimensional nucleic acid scaf-
folds could also serve to physically compartmentalize
artificial biochemical reaction networks like natural
organelles, since they can be engineered to assemble
with high efficiency into vessels of arbitrary shape with
well-defined dimensions.45,90,91 Furthermore, due to
the relative ease of engineering nucleic-acid-based
reaction networks54 and the existence of numerous
elementary components such as aptamers, ribozymes,
and riboswitches, some of the first artificial biologi-
cal systems or organisms may have nucleic acids as
integral components of their information networks.
Although true bottom-up synthetic biology remains
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FIGURE 6 | Progression in DNA and RNA nanotechnology. In nature, DNA forms structures such as the Holliday junction (field: DNA, Natural
Past), which has inspired scientists to create more complex structures such as the rectangular DNA origami tile (DNA, Synthetic Present). In the future,
such tiles may be used in fields including nanoelectronics as a scaffold for plasmonic circuit components to generate circuits that mimic neuron
behavior (DNA, Combined Future). As the simple example in the figure depicts, a new circuit connection (purple) may be strengthened by repeated
cooperative stimulation from excitatory pathways (green and blue) and hindered by the stimulation from an inhibitory pathway (orange). In nature,
RNA plays a catalytic role in peptide bond formation by the ribosome, arguably the most important enzyme on earth (RNA, Natural Past). The
catalytic and exquisite molecular recognition activity of RNA is exploited in (deoxy)ribozyme computing (RNA, Synthetic Present), which may be used
in the future for complex therapeutic nanomedicine applications. For instance, a drug carrier, specifically delivered to a diseased cell through
endocytosis triggered by binding to a protein on the cell surface, opens after entering the cell to release the drug (RNA, Combined Future). The
contents of the drug carrier include a microRNA mimic that causes repression of a specific protein that otherwise would inhibit the surface marker,
resulting in a cell that becomes more receptive to the drug carriers.
an elusive prospect for now, nucleic acid scaffolds and
devices are beginning to serve as a useful means to per-
turb biochemical networks.92–94 Since DNA origami
are stable in cells93,94 and cell lysate,95 even more
complex structures may soon find similar uses in inter-
facing with and programming of natural biological
pathways.
EMERGENT INTERDISCIPLINARY
FIELDS
Beyond the horizon of advantageous applications in
more or less well-established fields, it is illuminating
to explore the current state of some emerging
interdisciplinary fields (Figure 5) to better understand
how they are expected to benefit from future
advancements in nucleic acid nanotechnology.
Nanoelectronics
There exists a strong effort to make more highly
sophisticated, conveniently sized electronic devices,
requiring the further minimization of electronic com-
ponents. Currently, top-down-produced assemblies
are limited by the size of nanowires and use of litho-
graphic techniques to tens of nanometers in spatial
resolution. The wires are also limited in the flux of dig-
ital information they are able to transport when com-
pared to optical digitization techniques such as optical
fibers.96 Exploiting plasmonic properties between pre-
cisely placed nanoparticles is a plausible alternative.
Positioned using nucleic acid scaffolds, such an archi-
tecture would not only allow for signal enhancement
of the propagated information but also, theoretically,
the nanoparticles could behave as various, reconfig-
urable circuit components based on their materials
and geometries97 (Figure 6). Integrating this approach
with established lithographic techniques will lead to
synergy. Scaffolded components could also serve as
templates for metal deposition to generate solid-state
devices with nanometer precision, although it will
be necessary to develop methods for sustaining the
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template in the adverse conditions required for depo-
sition. Arraying various bottom-up circuit elements
using top-down assembling techniques may generate
larger, more complex circuits.
Alternative Energy
Rising global demand for energy and concerns about
the environmental impact of fossil fuel use motivate
the search for viable alternative energy sources.98,99
While progress has been made toward improving
alternative energy production and storage using
nanomaterials, emphasis has been placed on inorganic
materials rather than biomolecules. Owing to their
complexity, stand-alone nucleic acid nanodevices are
not likely to meet large-scale energy needs anytime
soon but become more formidable when combined
with living systems or inorganic materials. For
example, genetically encoded nucleic acid scaffolds
can be used to increase the flux through engineered
biochemical pathways by colocalizing functionally
related enzymes, including in the production of fuels
such as hydrogen.100 Nanoelectronic and photonic
devices constructed using nucleic acid scaffolds
and suitable chromophores could, with sufficient
improvements in efficiency, mimic photosynthetic
antenna complexes for nanoscale solar energy
harvesting.
Nanomedicine
Nanomedicine has been defined as the utilization
of nanotechnology for medicinal purposes including
diagnostic assays, therapeutic agents, and monitoring
devices.101 One of the current main objectives in
the field is targeted drug delivery in which a drug
carrier is able to selectively deliver a drug only to
diseased cells, resulting in lower drug dosages and
reduced harm to healthy cells.101 Three-dimensional
DNA smart materials have several features that
make them appealing candidates for nanocarriers:
they are biocompatible; they can selectively contain
particles, fully encapsulate them, and release them
when presented with a trigger; the exteriors may
be decorated with targeting signals; and differing
functional components may be incorporated into
their design with defined spatial positioning. Current
designs initiate cargo release by introducing a
nucleic acid strand to the carrier’s environment.90 By
alternatively incorporating functional strands that are
sensitive to natural changes in cellular environments,
such as potassium-sensitive deoxyribozymes or DNA
strands that undergo conformational changes in
response to pH,93 or an intrinsic cellular component,
cargo release may be controlled intracellularly by
natural means (much like intracellular genome
release from a viral capsid102). Computational
nucleic acid devices that mimic ncRNAs are being
created to implement this goal by using self-
cleaving deoxyribozyme hairpins that contain within
their sequence a short ssDNA strand that is
complementary to the portion of mRNA needing
to be suppressed but that is not active unless
triggered to be cleaved by disease indicators in
the cellular environment.54,66,103 These devices could
be integrated with the nanocarrier design to be
transported only to the diseased cells. Beyond that,
complex molecular ‘communities’ could integrate
biosensors, molecular computation, and chemical
synthesis to diagnose and treat illnesses at the
level of individual cells. For instance, one such
system might enter a cell through a carrier-mediated
interaction, detect abnormal levels of a certain
subset of messenger RNAs, compute the probability
that a given cell is cancerous, and then decide
whether to initiate apoptosis through an intrinsic
cellular pathway (Figure 6). While such an application
remains technically very challenging and expensive,
most of the required device classes have been
constructed.
DNA does have the disadvantage that it
is susceptible to nucleases, potentially leading to
release of cargo before triggered to do so. To
overcome this challenge, modified nucleic acids may
be incorporated,104 although any foreign materials
proposed for therapeutic use will need to be rigorously
tested for cytotoxicity and unexpected side effects.
Before these devices can be used as therapeutic agents,
fail-safe features (that lead, for example, to instability
of the device outside of its target area) will need to be
included in the design to prevent any undesired side
effects.
Another primary objective of nanomedicine is
the creation of point-of-care devices, which provide
a convenient way of testing and diagnosing a patient
immediately. Biosensors constructed with top-down
techniques hold much promise for this goal. How-
ever, the currently limited sensitivity of biosensors
generally requires the amplification of the analyte, typ-
ically accomplished using polymerase chain reaction,
which limits the detection efficiency.82 Plasmonics
may help amplify fluorescent signals, enabling a bind-
ing event to be detected even with low concentrations
of the analyte.72 Integration of biosensors with nano-
electronic devices could potentially accomplish the
types of analysis required to accurately diagnose
a patient.
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CONCLUSIONS
Nucleic acid nanotechnology has come a long way
since its inception a quarter century ago. It has
advanced from purely static scaffolds to dynamic
functional devices that include other natural and syn-
thetic materials. These advances have been further
aided by the recent emergence and exploitation of
single molecule tools, for example, super-resolution
single-molecule fluorescence microscopy,47,52,105,106
that can monitor the dynamic (bio)chemical reac-
tions, actuation, movement (diffusion), and integrity
of individual nanodevices. The resultant nanodevices
show great promise for useful future applications in a
broad variety of fields as sampled here. It is even more
exciting to contemplate that the precise structures
and functional versatility of devices such as these will
spawn new applications and perhaps entire new fields
that lie beyond the current bounds of our insight.
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